ELOX - Company ID 0001035354
Eloxx Pharmaceuticals, Inc. (ELOX) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $0.00 | -100.0% |
| FY 2024 | $6.36M | - |
| FY 2023 | $0.00 | -100.0% |
| FY 2014 | $182.23K | +2230.6% |
| FY 2013 | $7.82K | -96.1% |
| FY 2012 | $200.00K | +42.9% |
| FY 2010 | $140.00K | - |
Eloxx Pharmaceuticals, Inc. (ELOX) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2010 and fiscal 2025, Eloxx Pharmaceuticals, Inc.'s revenue declined from $140.00K to $0.00.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.